CulebrasCruz Profile Banner
Antonio Cruz-Culebras Profile
Antonio Cruz-Culebras

@CulebrasCruz

Followers
1K
Following
5K
Media
496
Statuses
5K

Tuits y RT personales #stroke #NeuroTwitter #neurology #ictus #neurologia #medicina #medicine #healthcare

Madrid, Comunidad de Madrid
Joined May 2020
Don't wanna be here? Send us removal request.
@CulebrasCruz
Antonio Cruz-Culebras
2 years
1
3
9
@maor_elad
Elad Maor
2 days
@NEJM Why does the most critical data , 61% increased risk of ischemic stroke in the device arm, is hidden in supplementary table 17 ? This should be in the abstract , main figures and main tables.
7
26
142
@CulebrasCruz
Antonio Cruz-Culebras
4 days
Después de las alucinaciones bibliográficas, también está el problema de la adulación de la IA. Ojo a los abusadores de gpts
@EricTopol
Eric Topol
4 days
The problem of AI sycophancy addressed in the new issue: @ScienceMagazine cover and original research by @chengmyra1 and colleagues https://t.co/P8112DRIIH
0
0
0
@Jeibros
Julián Estévez
5 days
¿Prohibir el móvil en clase ha mejorado el rendimiento en los colegios de Holanda? Holanda lleva 2 años sin móviles en las aulas y descubren que los alumnos... hablan entre ellos, se concentran más y sacan mejores notas. Nadie lo vio venir. 🤯 https://t.co/g3MNidXUXU
Tweet card summary image
bbc.com
Two years ago the Netherlands banned phones in schools. Now the government wants to go further, pushing to restrict social media for under‑16s.
109
4K
10K
@JAMA_current
JAMA
7 days
📊 JAMA Clinical Guidelines Synopsis: The 2025 ACC/AHA guideline recommends home and office #BloodPressure monitoring to confirm diagnosis and titrate medications, with a target blood pressure of <130/80 mm Hg for most adults. https://t.co/WKRTf0icSx
2
139
500
@CulebrasCruz
Antonio Cruz-Culebras
7 days
Ya está aqui su doctor de IA, con sus consejos inexactos o tratamientos incorrectos que perjudicarán, o peor aún, matarán, al paciente, y en que cualquier medida de seguridad no logrará detectar los errores. La FDA qué dirá? 🤔
@martinvars
Martin Varsavsky
7 days
Anunciamos el comienzo de Certuma la empresa que quiere que la gente que hoy tiene dificultades para acceder a un médico pueda llevar uno en su bolsillo. Pero a diferencia de la IA actual que sea legal y aprobada por la FDA y otros entes reguladores médicos.
0
0
0
@MicieliA_MD
Andrew Micieli
10 days
The Pitt Case (S02E08): Middle age women presents with painless monocular vision loss 1 hour from onset. VA light perception, and fundus photos show signs of CRAO (confirmed by ophtho). CTA negative. Would you recommend thrombolysis? 🤷🏻‍♂️ #stroke #neurology #MedEd
19
16
85
@CulebrasCruz
Antonio Cruz-Culebras
10 days
Las ACAs van fatal. Una prueba mas
@stephanamayer
Stephan A Mayer
10 days
Observational study of 95 ACA LVO patients. 92% of occlusions were A2 or distal. 80% got IV thrombolysis. All treated medically. Poor outcome (mRS 3-6) at 3 months in 49%. Even worse with hemorrhagic transformation. Predictors of poor outcome: increasing age, high NIHSS,
0
0
2
@EricTopol
Eric Topol
13 days
Neurodegenerative diseases at the single-cell level, a powerful tool to differentiate and better understand https://t.co/Pkz4qW0ELM @jclinicalinvest
2
23
117
@CulebrasCruz
Antonio Cruz-Culebras
15 days
Ante el repunte de casos suben los riesgos de la secuela infrecuente del sarampión: "De repente con 10 años tiene demencia" | Salud
Tweet card summary image
elmundo.es
El auge de los contagios de sarampión también abre la puerta a que aparezcan secuelas infrecuentes. «En los países con menores recursos y menos acceso a la vacuna sí se...
0
0
1
@almucastro01
Almudena Castro Conde
17 days
Mi resumen de las guías de lípidos 2026 ACC/AHA ⚠️GRAN CAMBIO EN ENFERMEDAD CARDIOVASCULAR⚠️ https://t.co/mzawsUV4zj Pero empecemos por el principio: 1. Se prefiere MH o S/NIH al Fridewald para estimar LDL✅ 2. Apo B para decidir si intensificación de tto. ‼️ojo que bajan a
9
167
557
@CulebrasCruz
Antonio Cruz-Culebras
15 days
Utilisimo paper. Guárdese 👁️ ‼️
@JAMANeuro
JAMA Neurology
15 days
Among patients with #Stroke and #PatentForamenOvale, the PASCAL classification system identified those likely to benefit from closure and those at risk of increased atrial fibrillation. https://t.co/ydBeuC8MOe
0
2
7
@ShadiYaghi2
Shadi Yaghi
16 days
The new AHA lipid guidelines are out, recommending a target LDL < 55 mg/dL in very high risk patients (e.g. symptomatic ICAD or ECAD). This can be achieved by high dose statin, or adding ezetemibe, PCSK9 inhibitors, or other treatments to high dose statin.
Tweet card summary image
ahajournals.org
AIM The “2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia” retires and replaces the “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA...
@ChaturvediNeuro
Seemant Chaturvedi
16 days
Patients with intracranial athero should now be targeted to LDL<55 mg/dl, given the new ACC/AHA lipid guidelines. This should be adopted in CAPTIVA and other ongoing trials, as well as routine practice @BrianHoh1 @ESOstroke @WorldStrokeOrg @AHAScience
2
36
89
@Teebi_MD
Ahmed Teebi, MD MPH MSc(Ox)🗝️
17 days
🧵The 2026 ACC/AHA Dyslipidemia Guidelines are officially out! Replacing ones from 2019. Key changes 👇 ✅Lower LDL-C goal (<70 & <55 for very high risk) ✅Universal Lp(a) screening ✅ApoB as tiebreaker when LDL at goal ✅Lower threshold to start statin for 1ry prevention
6
55
129
@ScholarshipfPhd
Scholarship for PhD
19 days
Artifcial intelligence-assisted academic writing: recommendations for ethical use
4
173
744
@IntJStroke
International Journal of Stroke
18 days
🫀🧠CATCH-AF score provides a robust, interpretable, and easily applicable tool for predicting atrial fibrillation after ESUS 👉✅Supports targeted & cost-effective rhythm monitoring Read about CATCH-AF here!⬇️ https://t.co/1SY4pFs2BQ @luciodanna2
0
7
19
@NEJM
NEJM
19 days
In an international, randomized trial involving patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during the 3-month treatment period. Full COBRRA trial results:
8
387
1K
@jramonfernandez
Joserra
20 days
Recordad este nombre: panencefalitis esclerosante subaguda. La complicación mortal del sarampión que se desarrolla años después de haber pasado la enfermedad. https://t.co/QI4mgkxooB
Tweet card summary image
nypost.com
Even those who make a full recovery from the initial infection face a lurking threat: a deadly disease that remains latent until striking — and killing — years later.
19
534
912
@CulebrasCruz
Antonio Cruz-Culebras
22 days
“La tecnología nos quitará los trabajos” y así desde hace 120 años
0
0
0
@EricTopol
Eric Topol
24 days
Interested in the latest sleep science and getting better quality sleep? New Ground Truths with Prof Yo-El Ju, @WashUNeurology https://t.co/2lV3Fw6cwg SRI-sleep regularity index
6
64
259